Transverse B-Lynch in Management of Placenta Accreta

Evaluation of the Efficacy of Transverse B-Lynch in Management of Placenta Accreta

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02943421

Enrollment

Registered

2016-10-24

Start date

2016-12-01

Completion date

2018-05-05

Last updated

2018-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decrease Maternal Morbidity

Brief summary

Placenta accreta is considered a severe pregnancy complication that may be associated with massive and potentially life-threatening intrapartum and postpartum hemorrhage. Life-threatening bleeding is the most common complication to be associated with this condition; the average blood loss at time of delivery is reported to be 3000-5500 mL, which leads to significant postoperative morbidity and death.

Interventions

PROCEDURETransverse B-Lynch suture

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

1\. All pregnant women with placenta previa as diagnosed by ultrasound with suspicion of abnormal placentation by Doppler us, confirmed intraoperatively undergoing either emergent or elective cesarean

Exclusion criteria

1. Patients who will be managed by hysterectomy 2. Patients who will be managed by conservative leaving the placenta in-situ

Design outcomes

Primary

Measure	Time frame
Estimated intraoperative blood loss	30 min

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026